Cardiovascular Diseases & Diagnosis

Bendaas Djamel

Publications

• Case Report
  Flecainide Induced Ventricular Arrhythmias in Atrial Fibrillation
  Author(s): Manish Barman and Bendaas DjamelManish Barman and Bendaas Djamel
  
  Purpose: Flecainide is a class 1C antiarrhythmic drug especially used for the management of supraventricular arrhythmia. Flecainide also has a recognized proarrhythmic effect in patients treated for ventricular tachycardia. It is used to treat a variety of cardiac arrhythmias including paroxysmal fibrillation, Paroxysmal Supraventricular tachycardia and ventricular tachycardia. Flecainide works by regulating the flow of sodium in the heart, causing prolongation of the cardiac action potential. The proarrhythmic effects however noted are not widely reported. Method: We report a case of paroxysmal atrial fibrillation with structurally normal heart who was treated with oral Flecainide. Despite subjective improvement and no adverse events [QTc prolongation] a repeat holter detected him to have multiple short non sustained ventricular arrhythmias.. Read More»
  DOI: 10.4172/2329-9517.1000156

  Abstract PDF